Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria.
Discovered in the early 1960s as a T cell cytokine, the protein mediator known as macrophage migration inhibitory factor (MIF) has been found recently to be a pituitary peptide released during the physiological stress response, a proinflammatory macrophage cytokine secreted after LPS stimulation, and a T cell product expressed as part of the antigen-dependent activation response. We report herein that MIF also plays a critical role in the innate host response to staphylococcal and streptococcal exotoxins. In RAW 264.7 or elicited mouse peritoneal macrophages, peak MIF secretion was induced by concentrations of the staphylococcal toxic shock syndrome (TSS) toxin 1 (TSST-1) and the streptococcal pyrogenic exotoxin A as low as 10 pg/ml. Moreover, dose-response studies of splenocyte cytokine production showed that lower concentrations of TSST-1 (10 pg/ml) were needed to release MIF than to induce interleukin 2 or interferon-gamma secretion (1 ng/ml). We also studied the effect of neutralizing anti-MIF antibodies on TSST-1-induced lymphocyte proliferation and lethal toxic shock. Pretreatment of C57BL/6 mice with anti-MIF antibody 2 hr before TSST-1 injection prevented spleen enlargement and reduced by 50% the proliferation of splenocytes measured ex vivo. In a lethal mouse model of TSST-1-induced shock, anti-MIF antibody increased survival from 8% to 54% (P < 0.0001). These studies indicate that Gram-positive exotoxins are extremely potent inducers of MIF secretion and establish a critical role for MIF and the macrophage in the pathogenesis of the TSSs and in the innate immune response.
Calandra
T
T
Laboratory of Medical Biochemistry, The Picower Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA.
Spiegel
L A
LA
Metz
C N
CN
Bucala
R
R
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001427:Bacterial Toxins; D002455:Cell Division / Q000276:immunology; D002478:Cells, Cultured; D004195:Disease Models, Animal; D004768:Enterotoxins / Q000494:pharmacology; D005098:Exotoxins / Q000494:pharmacology*; D006094:Gram-Positive Bacteria / Q000276:immunology*; D007249:Inflammation / Q000276:immunology; D007371:Interferon-gamma / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects*; D008263:Macrophage Migration-Inhibitory Factors / Q000276:immunology / Q000502:physiology*; D017737:Macrophages, Peritoneal / Q000378:metabolism*; D051379:Mice; D010902:Pituitary Gland / Q000378:metabolism; D012772:Shock, Septic / Q000276:immunology; D013154:Spleen / Q000378:metabolism; D013210:Staphylococcus / Q000276:immunology; D013291:Streptococcus / Q000276:immunology; D018089:Superantigens
D000906:Antibodies; D001427:Bacterial Toxins; D004768:Enterotoxins; D005098:Exotoxins; D007376:Interleukin-2; D008263:Macrophage Migration-Inhibitory Factors; D018089:Superantigens; C030107:enterotoxin F, Staphylococcal; D007371:Interferon-gamma